| Jessica Cestare, | |
|
1925 Pacific Ave Fl 5, Atlantic City, NJ 08401-6713 | |
| (609) 441-2122 | |
| Not Available |
| Full Name | Jessica Cestare |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1925 Pacific Ave Fl 5, Atlantic City, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194501304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 40QA02197000 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Cestare, 214 56th St, Sea Isle City, NJ 08243-1506 Ph: () - | Jessica Cestare, 1925 Pacific Ave Fl 5, Atlantic City, NJ 08401-6713 Ph: (609) 441-2122 |
News Archive
Whether you live in Haiti or in Harlem, the impact of poverty is the same. Children suffer from poor nutrition, environmental degradation, violence and poor development in the U.S. just as they do in less developed nations, and the consequences can be equally profound, according to Dr. Danielle Laraque, MD, president of the Academic Pediatric Association (APA).
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
It seems the jet setting air traveller with tuberculosis (TB) is not quite as dangerous as first thought. According to a federal health official, American lawyer Andrew Speaker has a less severe form of TB than previously diagnosed.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted the Company's New Drug Application for its investigational antibiotic tedizolid phosphate (TR-701) with Priority Review. The FDA has assigned a Prescription Drug User Fee Act action date of June 20, 2014. Cubist is seeking FDA approval of tedizolid for the treatment of acute bacterial skin and skin structure infections.
The National Academy of Medicine today announced Daniel Weinberger is the recipient of the 2019 Rhoda and Bernard Sarnat International Prize in Mental Health, for his fundamental role in elucidating the biological origins and genetic expressions of schizophrenia, and for transforming how clinicians, researchers, and the public understand mental illness.
› Verified 7 days ago
Dolores K Wohler, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1801 Atlantic Avenue, First Floor, Atlantic City, NJ 08401 Phone: 609-547-2400 Fax: 609-486-5053 | |
Seashore Physical Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1801 Atlantic Avenue, First Floor, Atlantic City, NJ 08401 Phone: 609-570-2400 Fax: 609-541-4131 | |
James M Foy, MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2419 Atlantic Ave, Atlantic City, NJ 08401 Phone: 609-347-9075 Fax: 609-347-8185 | |
Mir Shithil, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 256 Nevada Ave, Atlantic City, NJ 08401 Phone: 609-665-3988 | |
Sarah Cifaloglio, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1801 Atlantic Ave, Atlantic City, NJ 08401 Phone: 609-570-2400 |